125 related articles for article (PubMed ID: 14526436)
1. Effect of estrogen on telomerase activity in human breast cancer cells.
Gao J; Chen D; Tian Y; Zhang J; Cai K
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(3):286-7, 293. PubMed ID: 14526436
[TBL] [Abstract][Full Text] [Related]
2. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
[TBL] [Abstract][Full Text] [Related]
3. Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation.
Babu RL; Naveen Kumar M; Patil RH; Devaraju KS; Ramesh GT; Sharma SC
Mol Cell Biochem; 2013 Aug; 380(1-2):143-51. PubMed ID: 23625206
[TBL] [Abstract][Full Text] [Related]
4. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.
Watts CK; Sweeney KJ; Warlters A; Musgrove EA; Sutherland RL
Breast Cancer Res Treat; 1994; 31(1):95-105. PubMed ID: 7981461
[TBL] [Abstract][Full Text] [Related]
5. Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17β-estradiol.
Ye X; Yuan L; Zhang L; Zhao J; Zhang CM; Deng HY
Asian Pac J Cancer Prev; 2014; 15(12):5001-7. PubMed ID: 24998578
[TBL] [Abstract][Full Text] [Related]
6. Emodin inhibits breast cancer cell proliferation through the ERα-MAPK/Akt-cyclin D1/Bcl-2 signaling pathway.
Sui JQ; Xie KP; Zou W; Xie MJ
Asian Pac J Cancer Prev; 2014; 15(15):6247-51. PubMed ID: 25124606
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.
Doisneau-Sixou SF; Sergio CM; Carroll JS; Hui R; Musgrove EA; Sutherland RL
Endocr Relat Cancer; 2003 Jun; 10(2):179-86. PubMed ID: 12790780
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.
Wang Z; Kyo S; Maida Y; Takakura M; Tanaka M; Yatabe N; Kanaya T; Nakamura M; Koike K; Hisamoto K; Ohmichi M; Inoue M
Oncogene; 2002 May; 21(22):3517-24. PubMed ID: 12032853
[TBL] [Abstract][Full Text] [Related]
9. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
Reddel RR; Sutherland RL
Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
[TBL] [Abstract][Full Text] [Related]
10. Effects of tamoxifen on telomerase activity in breast carcinoma cell lines.
Aldous WK; Marean AJ; DeHart MJ; Matej LA; Moore KH
Cancer; 1999 Apr; 85(7):1523-9. PubMed ID: 10193942
[TBL] [Abstract][Full Text] [Related]
11. [Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721].
Zeng XL; Tu ZG
Ai Zheng; 2004 Dec; 23(12):1655-9. PubMed ID: 15601555
[TBL] [Abstract][Full Text] [Related]
12. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens.
Wilcken NR; Prall OW; Musgrove EA; Sutherland RL
Clin Cancer Res; 1997 Jun; 3(6):849-54. PubMed ID: 9815758
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of estradiol and its analogs on cyclin D1 and CDK4 expression in estrogen receptor positive MCF-7 and estrogen receptor-transfected MCF-10AEwt5 cells.
Hong J; Shah NN; Thomas TJ; Gallo MA; Yurkow EJ; Thomas T
Oncol Rep; 1998; 5(5):1025-33. PubMed ID: 9683804
[TBL] [Abstract][Full Text] [Related]
14. Aryl hydrocarbon receptor-mediated antiestrogenicity in MCF-7 cells: modulation of hormone-induced cell cycle enzymes.
Wang W; Smith R; Safe S
Arch Biochem Biophys; 1998 Aug; 356(2):239-48. PubMed ID: 9705214
[TBL] [Abstract][Full Text] [Related]
15. Synergistic proliferative action of insulin-like growth factor I and 17 beta-estradiol in MCF-7S breast tumor cells.
Hamelers IH; van Schaik RF; van Teeffelen HA; Sussenbach JS; Steenbergh PH
Exp Cell Res; 2002 Feb; 273(1):107-17. PubMed ID: 11795951
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.
Mawson A; Lai A; Carroll JS; Sergio CM; Mitchell CJ; Sarcevic B
Mol Cell Endocrinol; 2005 Jan; 229(1-2):161-73. PubMed ID: 15607540
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity is associated with cell cycle deregulation in human breast cancer.
Landberg G; Nielsen NH; Nilsson P; Emdin SO; Cajander J; Roos G
Cancer Res; 1997 Feb; 57(3):549-54. PubMed ID: 9012489
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells.
Kilker RL; Hartl MW; Rutherford TM; Planas-Silva MD
J Steroid Biochem Mol Biol; 2004 Sep; 92(1-2):63-71. PubMed ID: 15544931
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 alpha differentially synchronizes estrogen-dependent and estrogen-independent human breast cancer cells in the G0/G1 phase of the cell cycle.
Paciotti GF; Tamarkin L
Anticancer Res; 1991; 11(1):25-31. PubMed ID: 1826821
[TBL] [Abstract][Full Text] [Related]
20. Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements.
Castro-Rivera E; Samudio I; Safe S
J Biol Chem; 2001 Aug; 276(33):30853-61. PubMed ID: 11410592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
